Smart Wocket Wallet

New Post Public Reply Private Reply Replies (0) Message Board
Roger Wilco
Smart Wocket Wallet Arrives

http://www.cutimes.com/2015/04/28/smart-wocke...et-arrives

Move over Google Wallet and Apple Pay, Wocket® is here.

The smart wallet, from Oxford, Conn.-based NXT-ID, works without a mobile phone or cloud, to carry up to 10,000 cards. Nowadays consumers seek ways to organize items previously carried in back pockets or purses onto mobile devices. Wocket protects all of private information inside an electronic vault while reducing the number of cards in a person’s wallet.

“Biometric and patent pending technologies make Wocket the smartest wallet on the market,”
Early access customers tested Wocket® at a large number of locations.

wocket-wallet53-crop-600x338.jpg

They confirmed that Wocket® supports a wide range of retailers and merchants, as well as ATMs, gas stations and point-of-sale terminals with dip style readers that require a full name which according to NXT-ID other emerging card technologies find difficult.

When making a purchase, a consumer selects the card via the touch screen, removes the WocketCard from the Wocket's back pocket, and swipes it like a typical credit card purchase. The WocketCard contains the user’s name, and signature.

It displays the last four digits of the card and the security code on the WocketCard's LCD screen.

To load Wocket, a user swipes cards directly into it using the included card reader. Wocket allows users to manually enter barcodes and text, such as contained for voter's registration, loyalty and/or membership cards.

ces-2015-wocket-digitizes-all-cards-your-wallet-into-one-single-secure-card.w654.jpg

Wocket protects whatever information is stored in on a tamper-proof, encrypted chip protected by a biometric voice print. Wocket users maintain full control over their information, so Wocket never uploads card data to a server, or store it, on devices such as a smartphone. Many products on the market rely on a smartphone, app and Internet connection. Wocket works all by itself!

Wocket can communicate with a phone or tablet using the Wocket app as a way to manage an account, and update its firmware.

Biometric authentication company NXT-ID announced Wocket, ® which works anywhere credit cards are accepted and only works with biometric authentication, will start shipping to pre-order customers next week.

"This is a significant milestone for the company as Wocket® enters the consumer market. We would like to express our appreciation to all our pre-order customers that have waited patiently to receive this revolutionary product." CEO Gino Pereira said.

Pereira added, "What we have achieved is truly unique and game-changing. We have developed a personal vault that not only protects your identity, but also enables you to pay with a new technology that also works with current payment systems that we use today."

NXT-ID, a biometric authentication company focused on the growing mobile commerce market, produces various Wocket's sizes with accessories. With the base accessory, Wocket is as small as 3.46 inches by 2.75 inches by .39 inches. Wocket is available for a pre-order price of $149.99 and requires an exclusive invite for purchase.

Many tech companies have already entered the wallet market hoping to capitalize on a growing payment trend. Cambridge, Mass.-based Forrester predicted that U.S. mobile payments will grow from $52 billion in 2014 to $142 billion by 2019.

The Federal Reserve painted a different picture. It said the 39% of mobile payment users who used their smartphone device to make payments at the POS terminal remained unchanged from 2013 to 2014.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

Updated Category News Views 4

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Continue Reading
Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Updated Category News Views 3

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Continue Reading
Tam-Peli Steps Up in SCLC Battle: Trial Insights

Updated Category News Views 5

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Continue Reading
Surfing Dogs Ride Waves, Support Orphan Pets

Updated Category News Views 3

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

Continue Reading
MRI Surveillance Gains Ground in Lung Cancer Care

Updated Category News Views 6

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Continue Reading
First-Time Homeowners: Unseen Pitfalls of Insurance

Updated Category News Views 3

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

Continue Reading
Ris-Rez May Set New Standard in Relapsed SCLC

Updated Category News Views 6

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Continue Reading
PwC US and India Unite for Global Consultancy Powerhouse

Updated Category News Views 6

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Continue Reading
UWM Faces Class Action Deadline: Key Insights for Investors

Updated Category News Views 2

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Continue Reading
Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 12

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading
More News Articles